1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (1521)
  2. Meeting Abstract (1232)
  3. Review (76)
  4. Editorial (34)
  5. Book Section (32)
  6. Research Letter (25)
  7. Conference Paper (15)
  8. Correspondence (7)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (2950)
  2. Hematologic Malignancies Research (2950)
  3. GSK Faculty (2412)
  4. Department of Medicine (2277)
  5. Hematologic Malignancies, Division of (2078)
  6. Sloan Kettering Institute Faculty (2026)

More Groups

People
  1. Michel Sadelain (582)
  2. David Scheinberg (499)
  3. Alexander Lesokhin (363)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (279)

More People

Years
  1. 2025 (32)
  2. 2024 (108)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (636)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (108)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (674)
  2. Nature Publishing Group (367)
  3. Elsevier Inc. (290)
  4. American Association for Cancer Research (245)
  5. Cell Press (116)
  6. American Society of Clinical Oncology (112)

More Publishers

Results (2950)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Peripheral neuropathy and monoclonal gammopathy of undetermined significance: A population-based study including 15,351 cases and 58,619 matched controls
    Meeting Abstract

    Rognvaldsson, S.; Steingrimsson, V.; Turesson, I.; Bjorkholm, M.; Landgren, C. O.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Multiple myeloma and comorbidity: A population-based study
    Meeting Abstract

    Sverrisdottir, I.; Rognvaldsson, S.; Turesson, I.; Hultcrantz, M.; Bjorkholm, M.; Landgren, C. O.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A phase 1b study of once-weekly carfilzomib combined with lenalido-mide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)
    Meeting Abstract

    Alsina, M.; Landgren, C. O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J.; Kovacsovics, T.; Vesole, D.; Fang, B.; Kimball, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating chemokines and angiogenesis markers and risk of multiple myeloma and its precursor
    Meeting Abstract

    Hofmann, J.; Landgren, C. O.; Landy, R.; Kemp, T.; Santo, L.; McShane, C.; Shearer, J.; Lan, Q.; Rothman, N.; Pinto, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Biomarker based targeting of the epichaperome as a novel therapeutic approach for multiple myeloma (MM)
    Meeting Abstract

    Lopes, E. C.; Wang, T.; Jayabalan, D.; Monge, J.; Taldone, T.; Contreras, J.; Yip, W.; Panchal, P.; Sharma, S.; Digwal, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Fractures and survival in multiple myeloma: Results from a population-based study
    Meeting Abstract

    Thorsteinsdottir, S.; Gislason, G.; Aspelund, T.; Sverrisdottir, I.; Landgren, C. O.; Turesson, I.; Bjorkholm, M.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Dynamic monitoring of minimal residual disease reveals its superior prognostic significance in multiple myeloma
    Meeting Abstract

    Jin, F. Y.; Landgren, C. O.; Dai, Y.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save